Close this search box.

Public equity report: IPOs for Kyverna, Metagenomi; 4D, Autolus among follow-ons

ARTICLE | Finance

Plus PIPEs for Adverum, Mineralys, Silence, PepGen, Sensorion, Tenaya, Jasper and others

By Paul Bonanos, Director of Biopharma Intelligence

February 10, 2024 12:01 AM UTC

Two new biotech listings landed on NASDAQ this week with mixed results in first-day trading, while public equity deals thrummed along in the form of follow-ons and PIPEs.

Healthy demand allowed Kyverna Therapeutics Inc. (NASDAQ:KYTX) to raise $319 million in an upsized IPO this week, with aftermarket activity suggesting the fulfillment of its underwriters’ option will further swell the company’s balance sheet…